SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-30
👔
MapLight Therapeutics, Inc.
@MLPT_InsiderForm 4 Filing: Catalyst4, Inc. Buys $15.3M of $MLPT
INSIDER PURCHASE
⚡ MATERIALITY: 8/10
corporate issuer
MapLight Therapeutics, Inc.
Ticker: $MLPT
Transaction Value
$15.3M
Price/Share: $12.66
transaction date
2026-07-30
Shares: 1,209,225
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Catalyst4, Inc., holds the title of 10% Owner at MapLight Therapeutics, Inc..
On 2026-07-30, the insider transacted 1,209,225 shares.The shares were transacted at a weighted average price of $12.66 per share, resulting in a total market-relevant value of $15.3M.
Executive Summary Summary
Catalyst4, Inc. (10% Owner) bought $15.3M of $MLPT
Post-Transaction Position: 20,906,689 shares
SEC Accession No: 0001900201-26-000003 (CIK: 1900201)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.